Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Giral

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|January 19, 2008
Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndromePhilippe Giral, Nelly Jacob, Caroline Dourmap, et al.
Fundamental & Clinical Pharmacology|May 5, 2006
Use of an indirect effect model to describe the LDL cholesterol-lowering effect by statins in hypercholesterolaemic patientsDemiana William Faltaos, Saïk Urien, Valérie Carreau, et al.
Gastroenterology|June 9, 2005
Sampling variability of liver biopsy in nonalcoholic fatty liver diseaseVlad Ratziu, Frédéric Charlotte, Agnès Heurtier, et al.
Journal of Lipid Research|September 2, 2016
Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemiaAlexina Orsoni, Patrice Thérond, Ricardo Tan, et al.
Hepatology (Baltimore, Md.)|October 31, 2009
Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trialVlad Ratziu, Fréderic Charlotte, Carole Bernhardt, et al.
Hormone Research|July 24, 2003
Lipoprotein lipase activity and common gene variants in severely hypertriglyceridemic patients with and without diabetesRita Chadarevian, Luc Foubert, Isabel Beucler, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 11, 2005
Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemiaMariame El Messal, Jean-Louis Beaudeux, Anas Drissi, et al.
Practical Laboratory Medicine|January 8, 2020
Evaluation of a semi-automatic isoelectric focusing method for apolipoprotein E phenotypingRanda Bittar, Alain Carrié, Georges Nouadje, et al.
Cardiovascular Drugs and Therapy|October 3, 2008
Effect of an educational program (PEGASE) on cardiovascular risk in hypercholesterolaemic patientsEric Bruckert, Philippe Giral, François Paillard, et al.
Archives of Cardiovascular Diseases|December 9, 2008
A randomised trial of three counselling strategies for lifestyle changes in patients with hypercholesterolemia treated with ezetimibe on top of statin therapy (TWICE)Philippe Gabriel Steg, Jean-Claude Verdier, François Carré, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Arteriosclerosis, Thrombosis, and Vascular Biology|January 19, 2008
Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndromePhilippe Giral, Nelly Jacob, Caroline Dourmap, et al.
Fundamental & Clinical Pharmacology|May 5, 2006
Use of an indirect effect model to describe the LDL cholesterol-lowering effect by statins in hypercholesterolaemic patientsDemiana William Faltaos, Saïk Urien, Valérie Carreau, et al.
Gastroenterology|June 9, 2005
Sampling variability of liver biopsy in nonalcoholic fatty liver diseaseVlad Ratziu, Frédéric Charlotte, Agnès Heurtier, et al.
Journal of Lipid Research|September 2, 2016
Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemiaAlexina Orsoni, Patrice Thérond, Ricardo Tan, et al.
Hepatology (Baltimore, Md.)|October 31, 2009
Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trialVlad Ratziu, Fréderic Charlotte, Carole Bernhardt, et al.
Hormone Research|July 24, 2003
Lipoprotein lipase activity and common gene variants in severely hypertriglyceridemic patients with and without diabetesRita Chadarevian, Luc Foubert, Isabel Beucler, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 11, 2005
Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemiaMariame El Messal, Jean-Louis Beaudeux, Anas Drissi, et al.
Practical Laboratory Medicine|January 8, 2020
Evaluation of a semi-automatic isoelectric focusing method for apolipoprotein E phenotypingRanda Bittar, Alain Carrié, Georges Nouadje, et al.
Cardiovascular Drugs and Therapy|October 3, 2008
Effect of an educational program (PEGASE) on cardiovascular risk in hypercholesterolaemic patientsEric Bruckert, Philippe Giral, François Paillard, et al.
Archives of Cardiovascular Diseases|December 9, 2008
A randomised trial of three counselling strategies for lifestyle changes in patients with hypercholesterolemia treated with ezetimibe on top of statin therapy (TWICE)Philippe Gabriel Steg, Jean-Claude Verdier, François Carré, et al.
Pageof 14